<?xml version="1.0" encoding="UTF-8"?>
<xml>
 <records>
  <record>
   <ref-type name="Journal Article">17</ref-type>
   <contributors>
    <authors>
     <author>Stavros Gravas</author>
     <author>Georgios Chasiotis</author>
     <author>Mauro Gacci</author>
     <author>Gokhan Calik</author>
     <author>Andrea Liaci</author>
     <author>Athanasios Dellis</author>
     <author>Petros Sountoulides</author>
     <author>M. Pilar Laguna</author>
     <author>Jean De La Rosette</author>
    </authors>
   </contributors>
   <titles>
    <title>The feasibility and acceptability of a (mobile) application for men with lower urinary tract symptoms: a pilot study</title>
   </titles>
   <keywords>
    <keyword>mobile applications</keyword>
    <keyword>lower urinary tract symptoms</keyword>
    <keyword>prostatic hyperplasia</keyword>
    <keyword>Scopus</keyword>
    <keyword>Web of Science</keyword>
    <keyword>Белый список</keyword>
   </keywords>
   <dates>
    <year>2025</year>
    <pub-dates>
     <date>2026-06-23</date>
    </pub-dates>
   </dates>
   <doi>10.23736/s2724-6051.25.06352-9</doi>
   <journal>MINERVA UROLOGY AND NEPHROLOGY</journal>
   <abstract>BACKGROUND: The growing use of smartphones offers a key opportunity to monitor BPO/LUTS through well-designed medical apps. The primary objective of the study was to assess the feasibility and acceptability of a mobile app&#13;
(MyBPHCare) for men with lower urinary tract symptoms (LUTS). Secondary objectives included medical adherence&#13;
using electronic reminders and compliance of treatment with current guidelines.&#13;
METHODS: This was an observational cohort pilot study conducted in Greece, Türkiye, and Italy. Patients with LUTS,&#13;
treatment-naïve or under treatment, older than 40 years were eligible. Patients received standard care according to phy- sician’s practice and duration of follow-up was 6 months. Standard questionnaires, diagnostic tools, medication, and&#13;
follow-up visits were employed. Feasibility, acceptance, and satisfaction were assessed using a standardized, translated&#13;
and validated app rating user questionnaire (uMARS). Patients’ adherence to treatment and physicians’ with guidelines&#13;
were also recorded.&#13;
RESULTS: From a total of 157 patients, 68.15% filled in the uMARS questionnaire. All uMARS mean scores ranged&#13;
between “Acceptable” and “Good”: App Quality (3.43), Engagement (3.21), Functionality (3.47), Aesthetics (3.37), and&#13;
Information (3.68). 96.3% of the participants would recommend using the app. Recorded adherence to medication was&#13;
47.85%, while a discrepancy between guidelines and real-life practice was found.&#13;
CONCLUSIONS: MyBPHCare app is a possibly feasible application for virtually monitoring men with LUTS with good&#13;
acceptance from the patients.</abstract>
   <urls>
    <web-urls>
     <url>https://repo.bashgmu.ru/publication/5541</url>
    </web-urls>
    <pdf-urls>
     <url>https://repo.bashgmu.ru/files/5735</url>
    </pdf-urls>
   </urls>
  </record>
 </records>
</xml>
